Who invested in Praxis Precision Medicines?
Praxis Precision Medicines's investors include Novo Holdings, Cormorant Asset Management and Adage Capital Management.

United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$575Mraised across 1 round since 2026, from 1 source
From Praxis Precision Medicines's own website and the SEC filings it signed: 1 founder, 18 on the team.
On the board, as filediAlfred SandrockAri BrettmanGregory NordenNicholas GalakatosPaul MedeirosStefan VitorovicThomas Dyrberg
AdvisersMatt Might
Praxis Precision Medicines's investors include Novo Holdings, Cormorant Asset Management and Adage Capital Management.
Praxis Precision Medicines has raised $575M across 1 round since 2026.
Praxis Precision Medicines's most recent round was an Undisclosed round of $575M in Jan 2026.
Its most recent round, $575M in Jan 2026, is also its largest on record.
Praxis Precision Medicines's first round on record, in Jan 2026, was backed by Novo Holdings, Cormorant Asset Management and Adage Capital Management.
Praxis Precision Medicines's latest named round is an Undisclosed round, in Jan 2026.
Praxis Precision Medicines is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.